HolmesAI’s CLholmes AI Platform Predicts Cardiac Arrest Risk Within 24 Hours
Updated Published Cached
-
Image: YonhapThis file photo, provided by HolmesAI Co., shows its Chief Executive Officer (CEO) Lim Dong-seok (L) and Lee Kwang-hyun, co-founder and chief strategy officer of HolmesAI, posing for a photo at the 2025 Consumer Electronics Show in Las Vegas, in January 2025. (PHOTO NOT FOR SALE) (Yonhap) Source Full size
AI platform CLholmes predicts 24‑hour cardiac arrest risk – HolmesAI’s new digital diagnostic tool analyzes electrocardiogram data to detect 21 types of cardiac arrhythmia and estimate the likelihood of cardiac arrest in the next day, aiming to enable home‑based monitoring and early intervention [1].
Developed with Seoul National University Hospital researchers – Professors Lee Hyung‑cheol and Lee Hyun‑hoon collaborated with HolmesAI on the underlying technology, lending clinical expertise to the AI model [1].
Integrates real‑time ECG from wearables – CLholmes is designed to receive continuous ECG streams from devices such as smartwatches, delivering immediate alerts to patients, their physicians, and emergency medical centers when risk signals appear [1].
Won Innovation Award at 2025 CES – The platform earned the Innovation Award at the Consumer Electronics Show in Las Vegas, highlighting its prominence in the consumer‑tech and health‑tech sectors [1].
New York office opened to pursue global expansion – In the month preceding the announcement, HolmesAI established a New York office to introduce its wearable‑based digital health and AI model to international markets and accelerate a prevention‑centered health‑care ecosystem [1].
Company aims to protect lives beyond hospitals – HolmesAI’s strategy focuses on shifting care from hospital settings to everyday environments, using AI‑driven alerts to prevent cardiac events before they occur [1].
- Company official: “Through the establishment of our New York office, we aim to introduce our wearable‑based digital health and medical AI convergence model to the global market and accelerate the development of a prevention‑centered health care ecosystem that protects lives beyond hospital settings.” – spokesperson for HolmesAI, in a press release [1].